By law, Medicare Part D cannot cover drugs prescribed strictly for weight loss, which is why a GLP-1 may be covered for a Medicare patient with type 2 diabetes but not for obesity alone
While early studies are promising, these drugs are not currently approved for asthma treatment
Make the pharmacist aware and ask the patient if they would be open to having a consultation with the pharmacist
At PeterMD, patients may be prescribed a compounded GLP-1 formulation with B12 prepared by licensed pharmacies, designed to support metabolism, energy production, and sustainable weight loss under clinical supervision Hit Add To Cart, schedule your virtual visit, then your medication will be shipped directly to your door
The direct, quantified, longitudinal human measurements that would settle it are largely absent from the published cagrilintide monotherapy literature, and there is a credible mechanistic reason the tendency of long-acting gut-hormone agonists toward gastric-emptying tachyphylaxis, plus obesity-associated amylin-receptor down-regulation to suspect the gastric arm may attenuate even as central satiety persists
[PMID: 11742568] PubMed record related to this compound for laboratory literature review
